COVID-19 时代的激增应对能力:普通重症监护中神经重症监护的自然实验
该观察性队列研究纳入 Emory Healthcare 系统四家医院前三波 COVID-19 激增期间所有需重症监护的 COVID-19 患者,按收入普通重症医师或神经重症医师管理的 ICU 分组,排除原发神经系统诊断者。共 1141 例,普通重症医师组 1071 例,神经重症医师组 70 例;神经重症组更年轻(59 vs 65,p=0.027)、PaO2/FiO2 更高(153 vs 120,p=0.002)。倾向评分匹配后,ICU 人员配置与机械通气、肾脏替代治疗和血管升压药使用无相关性;神经重症医师管理的 COVID-19 单元住院死亡率和临终关怀转归相似(OR 0.9,95%CI 0.31-2.64,p=0.842)。结论认为神经重症医师提供了与普通 ICU 相当的转归,支持神经重症监护在满足神经危重症患者普通重症需求及作为普通重症激增资源方面的作用。
要点
- 神经重症医师管理的 COVID-19 ICU 与普通重症医师管理的 ICU 住院死亡率和临终关怀转归相似(OR 0.9,95%CI 0.31-2.64,p=0.842)。
- 倾向评分匹配后,ICU 人员配置与机械通气、肾脏替代治疗和血管升压药使用无相关性。
- 神经重症组患者更年轻(59 vs 65,p=0.027)且 PaO2/FiO2 更高(153 vs 120,p=0.002),基线其余特征相似。
- 共纳入 1141 例 COVID-19 重症患者,普通重症医师组 1071 例,神经重症医师组 70 例,排除原发神经系统诊断者。
适用人群与场景
- Emory Healthcare 系统四家医院前三波 COVID-19 激增期间所有需重症监护的 COVID-19 患者。
- 排除原发神经系统诊断的患者。
研究设计与关键结果
- 观察性队列研究,共 1141 例以 COVID-19 为主要诊断需 ICU 入院的患者,普通重症医师管理的 ICU 1071 例,神经重症医师管理的 ICU 70 例。
- 基线:神经重症医师管理 ICU 的患者更年轻(59 vs 65,p=0.027)且 PaO2/FiO2 更高(153 vs 120,p=0.002),其余基线人口学和表现特征相似。
- 倾向评分匹配后,ICU 人员配置与机械通气、肾脏替代治疗和血管升压药使用无相关性。
- 神经重症医师管理的 COVID-19 单元住院死亡率和临终关怀转归相似(OR 0.9,95%CI 0.31-2.64,p=0.842)。
证据类型、等级与局限
- 证据类型:观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,神经重症医师提供的重症监护转归与普通 ICU 相当,支持神经重症监护作为普通重症激增资源的可行性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: COVID-19 surges led to significant challenges in ensuring critical care capacity. In response, some centers leveraged neurocritical care (NCC) capacity as part of the surge response, with neurointensivists providing general critical care for patients with COVID-19 without neurologic illness. The relative outcomes of NCC critical care management of patients with COVID-19 remain unclear and may help guide further surge planning and provide broader insights into general critical care provided in NCC units.
METHODS: We performed an observational cohort study of all patients requiring critical care for COVID-19 across four hospitals within the Emory Healthcare system during the first three surges. Patients were categorized on the basis of admission to intensive care units (ICUs) staffed by general intensivists or neurointensivists. Patients with primary neurological diagnoses were excluded. Baseline demographics, clinical complications, and outcomes were compared between groups using univariable and propensity score matching statistics.
RESULTS: A total of 1141 patients with a primary diagnosis of COVID-19 required ICU admission. ICUs were staffed by general intensivists (n = 1071) or neurointensivists (n = 70). Baseline demographics and presentation characteristics were similar between groups, except for patients admitted to neurointensivist-staffed ICUs being younger (59 vs. 65, p = 0.027) and having a higher PaO2/FiO2 ratio (153 vs. 120, p = 0.002). After propensity score matching, there was no correlation between ICU staffing and the use of mechanical ventilation, renal replacement therapy, and vasopressors. The rates of in-hospital mortality and hospice disposition were similar in neurointensivist-staffed COVID-19 units (odds ratio 0.9, 95% confidence interval 0.31-2.64, p = 0.842).
CONCLUSIONS: COVID-19 surges precipitated a natural experiment in which neurology-trained neurointensivists provided critical care in a comparable context to general intensivists treating the same disease. Neurology-trained neurointensivists delivered comparable outcomes to those of general ICUs during COVID-19 surges. These results further support the role of NCC in meeting general critical care needs of neurocritically ill patients and as a viable surge resource in general critical care.
参考来源
- Philips S, Shi Y, Coopersmith CM, et al. Surge Capacity in the COVID-19 Era: a Natural Experiment of Neurocritical Care in General Critical Care. Neurocrit Care. 2022. PMID: 35831731. doi:10.1007/s12028-022-01559-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。